Navigation Links
Central Florida is International Destination for Unique, State-of-the-Art Procedure to Treat Common Digestive Ailment
Date:7/6/2009

Patient from Kuwait is first who has traveled overseas to U.S. for this innovative treatment of GERD, a condition suffered by millions of Americans. Surgeon performing procedure has highest success rate of any physician in the country.

Lady Lake, Florida (PRWEB) July 6, 2009 -- A patient from Kuwait selected Central Florida as the place to seek relief from a chronic condition that affects as many as 19 million Americans. On Tuesday, July 7, Professional Gastroenterology & Surgical Associates (PGSA) physicians Dr. William Todd Overcash, M.D. and Dr. Akram Ismail, M.D. will perform an incisionless trans-oral surgery to correct the patient's gastroesophageal reflux disease (GERD), more commonly known as acid reflux.

"The United States continues to be a leader in groundbreaking medical services and a draw for patients all over the world to get treatment," said Dr. Ismail. "We are so pleased that PGSA can offer our patients the renown expertise that Dr. Overcash provides working with an accomplished team of Gastrointestinal experts, making Central Florida an international destination for people seeking relief from their digestive ailments."

The woman, who is in her 50's, has long suffered from GERD, which happens when a muscle at the end of the esophagus does not close properly allowing the stomach contents to leak back, or reflux, into the esophagus and irritate it.

GERD, which is treatable, can often lead to more serious health problems including ulcers, cancer and pneumonia. GERD is often treated with surgery and/or medications that have side effects and can lose their effectiveness over time.

"I was part of a 2008 study that found 85% of patients remain symptom-free and off daily GERD medication at one year after undergoing this trans-ora
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
2. HealthCentral.com Launches Greeting Card Application on Facebook.com
3. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
4. Community Leaders to Host Press Event at L.A. Central Jail Urging Governor to Sign AB 1334
5. Aegis Selected by Community Medical Centers to Bring New Employer-Focused Wellness Program to Californias Central Valley
6. New England Journal of Medicine Selects ScholarOnes Manuscript Central for Online Peer Review
7. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
8. The HealthCentral Network Announces Participation in the Launch of Microsoft HealthVault
9. Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion
10. Biotech adds Central American markets to Sucanon distribution
11. Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Central Florida is International Destination for Unique, State-of-the-Art Procedure to Treat Common Digestive Ailment
Central Florida is International Destination for Unique, State-of-the-Art Procedure to Treat Common Digestive Ailment
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 1Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 2Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 3Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 4Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 1Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 2Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 3Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 4Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 6Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 7Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 8Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 9Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 10Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 11Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 12Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 13Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 14Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 15Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 16Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 17Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 18Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 19Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 20Geneticists hunt for scleroderma triggers 60340 1Geneticists hunt for scleroderma triggers 60340 2